108 results on '"CAMACHO-HUBNER, C."'
Search Results
2. IGF-1 LEVELS AND LEG EXTENSOR POWER IN SUBJECTS REHABILITATING FOLLOWING PROXIMAL FEMORAL FRACTURE
3. Predictors of the Outcome of Surgical Treatment in Acromegaly and the Value of the Mean Growth Hormone Day Curve in Assessing Postoperative Disease Activity
4. Insulin-Like Growth Factor I and the Development of Colorectal Neoplasia in Acromegaly*
5. Girls with virilisation in childhood: a diagnostic protocol for investigation
6. Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences
7. Individualised Growth Response Optimisation (IGRO): A Multi-Language Software Medical Device to Predict Growth Response in Children Treated With Growth Hormone (GH)
8. Pharmacokinetic studies of rhIGF-I/rhIGFBP-3 complex administered to patients with growth hormone insensitivity syndrome
9. Consensus statement: Childhood obesity
10. Insuline-Like Growth Factor I and the development of colorectal neoplasia in acromegaly
11. P02-42 Bioavailability of Pegvisomant 30mg/mL formulation compared to 15mg/mL Formulation: Pharmacokinetics, safety, and tolerability in healthy subjects
12. Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I
13. 218 Effects of insulin-like growth factor binding protein-3 on human malignant pleural mesothelioma cell growth and apoptosis
14. PRM12 - Individualised Growth Response Optimisation (IGRO): A Multi-Language Software Medical Device to Predict Growth Response in Children Treated With Growth Hormone (GH)
15. Interleukin-1beta (IL-1beta) and IL-6 modulate insulin-like growth factor-binding protein (IGFBP) secretion in colon cancer epithelial (Caco-2) cells
16. IGF-1 levels, leg extensor power and physical performance after proximal femoral fracture
17. Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years
18. Effects of Recombinant Human Insulin-Like Growth Factor I (IGF-I) Therapy on the Growth Hormone-IGF System of a Patient with a Partial IGF-I Gene Deletion
19. Dose-related effects of growth hormone on IGF-I and IGF-binding protein-3 levels in non-islet cell tumour hypoglycaemia
20. Elevated serum IGF-I is associated with an increased risk of colorectal neoplasia in acromegaly
21. Nutritional modulation of canine insulin-like growth factors and their binding proteins
22. Metabolic Effects of Adjuvant Recombinant Human Growth Hormone in Patients With Continuing Sepsis Receiving Parenteral Nutrition
23. Expression of IGF-I and IGF-binding protein genes in cirrhotic liver
24. CHARACTERISTICS OF PUBERTAL DEVELOPMENT IN INFLAMMATORY BOWEL DISEASE (IBD)
25. Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I.
26. Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion.
27. Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I.
28. Insulin‐like growth factor (IGF) binding to human fibroblast and glioblastoma cells: The modulating effect of cell released IGF binding proteins (IGFBPs)
29. Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity.
30. Hypoketotic Hypofattyacidaemic Hypoinsulinaemic Hypoglycaemia in a Child with Hemihypertrophy? A New Syndrome.
31. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene.
32. Is there a medical need to explore the clinical use of insulin-like growth factor I?
33. Assessment of growth hormone status in acromegaly: What biochemical markers to measure and how?
34. Insulin-like growth factor-I deficiency caused by a partial deletion of the IGF-I gene: Effects of rhIGFmi therapy
35. Acromegaly or chronic renal failure: a diagnostic dilemma
36. Phenotypic variability in growth hormone insensitivity
37. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life
38. Insulin-like growth factor-I and -II in combination inhibit the release of growth hormone-releasing hormone from the rat hypothalamus in vitro
39. Insulin-like growth factor (IGF)-binding protein release by human fetal fibroblasts: dependency on cell density and IGF peptides
40. Insulin-like growth factor binding protein-2 (IGFBP-2) levels are elevated in patients with acromegaly and colonic neoplasia
41. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults
42. Monitoring response to growth hormone replacement-an ideal model
43. Assessment of potential transthyretin amyloid cardiomyopathy cases in the Brazilian public health system using a machine learning model.
44. More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY.
45. Response to GH Treatment After Radiation Therapy Depends on Location of Irradiation.
46. Change in baseline characteristics over 20 years of adults with growth hormone (GH) deficiency on GH replacement therapy.
47. Targeted literature review of the humanistic and economic burden of adult growth hormone deficiency.
48. Improvements in Body Composition after 4 Years of Growth Hormone Treatment in Adult-Onset Hypopituitarism Compared to Age-Matched Controls.
49. Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY.
50. Secular Trends on Birth Parameters, Growth, and Pubertal Timing in Girls with Turner Syndrome.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.